PROPHYLAXIS IN SUBJECTS WITH SEVERE OR MODERATELY SEVERE HEMOPHILIA A: A MULTICENTER, OPEN-LABEL, RANDOMIZED, 2-ARM, PHASE 4 CLINICAL STUDY OF PREVIOUSLY TREATED PATIENTS WITH ADVATE (ANTIHEMOPHILIC FACTOR [RECOMBINANT] PLASMA/ALBUMIN-FREE METHOD)